Status:
COMPLETED
1-Year Follow up to the 1473-IMIQ Study
Lead Sponsor:
Graceway Pharmaceuticals, LLC
Conditions:
Keratosis
Eligibility:
All Genders
18+ years
Brief Summary
This is a 1-year follow-up study to evaluate the long-term effects in subjects who completely cleared their actinic keratosis (AK) lesions in the 1473-IMIQ study. The 1473-IMIQ study evaluated the saf...
Eligibility Criteria
Inclusion
- Subject had to participate in the 1473-IMIQ Study AND have had 100% clearance of AK lesions
Exclusion
- Did not use any topical preparations in the previous treatment area within 24-hours of the scheduled visit.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00114023
Start Date
January 1 2005
Last Update
February 19 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Little Rock, Arkansas, United States, 72205